Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations

Grzegorz Porębski; Jacek Gocki; Aldona Juchacz; Aleksandra Kucharczyk; Tomasz Matuszewski; Katarzyna Olejniczak; Małgorzata Sokołowska; Marcin Stobiecki; Ewa Trębas-Pietraś; Krystyna Obtułowicz

doi:10.5114/pja.2018.76680

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2018
vol. 5

Send email

Copy url:

abstract:

Guidelines/recommendations

Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations

Grzegorz Porębski

,

Jacek Gocki

,

Aldona Juchacz

,

Aleksandra Kucharczyk

,

Tomasz Matuszewski

,

Katarzyna Olejniczak

,

Małgorzata Sokołowska

,

Marcin Stobiecki

,

Ewa Trębas-Pietraś

,

Krystyna Obtułowicz

Alergologia Polska – Polish Journal of Allergology 2018; 5, 2: 109–120

DOI: https://doi.org/10.5114/pja.2018.76680

Online publish date: 2018/06/27

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Porębski G, Gocki J, Juchacz A, et al. Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations. Alergologia Polska - Polish Journal of Allergology. 2018;5(2):109-120. doi:10.5114/pja.2018.76680.

APA

Porębski, G., Gocki, J., Juchacz, A., Kucharczyk, A., Matuszewski, T.,  & Olejniczak, K. et al. (2018). Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations. Alergologia Polska - Polish Journal of Allergology, 5(2), 109-120. https://doi.org/10.5114/pja.2018.76680

Chicago

Porębski, Grzegorz, Jacek Gocki, Aldona Juchacz, Aleksandra Kucharczyk, Tomasz Matuszewski, Katarzyna Olejniczak,  and Małgorzata Sokołowska et al. 2018. "Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations". Alergologia Polska - Polish Journal of Allergology 5 (2): 109-120. doi:10.5114/pja.2018.76680.

Harvard

Porębski, G., Gocki, J., Juchacz, A., Kucharczyk, A., Matuszewski, T., Olejniczak, K., Sokołowska, M., Stobiecki, M., Trębas-Pietraś, E.,  and Obtułowicz, K. (2018). Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations. Alergologia Polska - Polish Journal of Allergology, 5(2), pp.109-120. https://doi.org/10.5114/pja.2018.76680

MLA

Porębski, Grzegorz et al. "Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations." Alergologia Polska - Polish Journal of Allergology, vol. 5, no. 2, 2018, pp. 109-120. doi:10.5114/pja.2018.76680.

Vancouver

Porębski G, Gocki J, Juchacz A, Kucharczyk A, Matuszewski T, Olejniczak K et al. Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations. Alergologia Polska - Polish Journal of Allergology. 2018;5(2):109-120. doi:10.5114/pja.2018.76680.

PlumX metrics:

The second part of the consensus statement aimed at management of hereditary angioedema (HAE). The currently available therapeutic options for acute and long-term treatment in HAE are presented in the light of the recently published evidence based research and recommendations. The specific situations are also addressed, namely, home treatment, management of patient with some coexisting medical conditions and management of selected subpopulations, including pregnant women and children. The significance of the close collaboration with patients is emphasized. The outcome of the statement is to improve management and uniform care of HAE patients in Poland.

keywords:

Management of hereditary angioedema with C1 inhibitor-deficiency – consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations

Grzegorz Porębski , Jacek Gocki , Aldona Juchacz , Aleksandra Kucharczyk , Tomasz Matuszewski , Katarzyna Olejniczak , Małgorzata Sokołowska , Marcin Stobiecki , Ewa Trębas-Pietraś , Krystyna Obtułowicz

hereditary angioedema, C1-inhibitor, management, treatment, recommendations

Grzegorz Porębski

,

Jacek Gocki

,

Aldona Juchacz

,

Aleksandra Kucharczyk

,

Tomasz Matuszewski

,

Katarzyna Olejniczak

,

Małgorzata Sokołowska

,

Marcin Stobiecki

,

Ewa Trębas-Pietraś

,

Krystyna Obtułowicz